Caisse DE Depot ET Placement DU Quebec Raises Stake in Humana Inc. (HUM)

Caisse DE Depot ET Placement DU Quebec raised its position in Humana Inc. (NYSE:HUM) by 0.1% during the first quarter, according to its most recent 13F filing with the SEC. The firm owned 286,300 shares of the insurance provider’s stock after buying an additional 200 shares during the period. Caisse DE Depot ET Placement DU Quebec owned approximately 0.19% of Humana worth $59,082,000 at the end of the most recent reporting period.

Several other hedge funds have also modified their holdings of the company. Glenview Capital Management LLC acquired a new stake in shares of Humana during the fourth quarter worth $1,288,203,000. FMR LLC boosted its stake in shares of Humana by 57.9% in the first quarter. FMR LLC now owns 5,050,853 shares of the insurance provider’s stock worth $1,041,184,000 after buying an additional 1,851,197 shares during the period. Norges Bank acquired a new stake in shares of Humana during the fourth quarter worth $251,291,000. Wellington Management Group LLP boosted its stake in shares of Humana by 2,651.1% in the first quarter. Wellington Management Group LLP now owns 775,755 shares of the insurance provider’s stock worth $159,915,000 after buying an additional 747,557 shares during the period. Finally, MARSHALL WACE ASIA Ltd acquired a new stake in shares of Humana during the first quarter worth $116,661,000. 98.92% of the stock is currently owned by institutional investors.

Institutional Ownership by Quarter for Humana (NYSE:HUM)

Shares of Humana Inc. (NYSE:HUM) traded down 0.64% during trading on Tuesday, reaching $233.99. 577,827 shares of the company were exchanged. Humana Inc. has a 52-week low of $150.00 and a 52-week high of $236.82. The stock has a 50-day moving average of $230.44 and a 200 day moving average of $213.49. The stock has a market capitalization of $33.77 billion, a P/E ratio of 23.85 and a beta of 0.90.

Humana (NYSE:HUM) last released its quarterly earnings results on Wednesday, May 3rd. The insurance provider reported $2.75 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $2.55 by $0.20. Humana had a return on equity of 14.38% and a net margin of 2.71%. The business had revenue of $13.76 billion during the quarter, compared to analysts’ expectations of $13.61 billion. During the same period in the previous year, the business posted $1.86 earnings per share. On average, equities analysts anticipate that Humana Inc. will post $11.15 earnings per share for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Monday, July 31st. Investors of record on Friday, June 30th will be given a $0.40 dividend. The ex-dividend date is Wednesday, June 28th. This represents a $1.60 dividend on an annualized basis and a yield of 0.68%. Humana’s payout ratio is 16.24%.

COPYRIGHT VIOLATION WARNING: “Caisse DE Depot ET Placement DU Quebec Raises Stake in Humana Inc. (HUM)” was first posted by Sports Perspectives and is the property of of Sports Perspectives. If you are accessing this news story on another website, it was copied illegally and republished in violation of U.S. & international copyright and trademark laws. The legal version of this news story can be read at https://sportsperspectives.com/2017/06/20/caisse-de-depot-et-placement-du-quebec-raises-stake-in-humana-inc-hum.html.

A number of analysts have weighed in on HUM shares. Jefferies Group LLC reissued a “buy” rating and set a $237.00 target price on shares of Humana in a report on Friday, March 24th. Deutsche Bank AG started coverage on shares of Humana in a report on Wednesday, April 5th. They set a “hold” rating and a $216.00 target price on the stock. Zacks Investment Research cut shares of Humana from a “buy” rating to a “hold” rating in a report on Monday, April 24th. Evercore ISI reissued an “overweight” rating on shares of Humana in a report on Monday, February 27th. Finally, Cantor Fitzgerald increased their target price on shares of Humana from $190.00 to $200.00 and gave the stock a “neutral” rating in a report on Wednesday, April 26th. Eight analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company. The company has a consensus rating of “Buy” and an average price target of $223.16.

In related news, VP Heidi S. Margulis sold 1,500 shares of Humana stock in a transaction dated Friday, May 26th. The stock was sold at an average price of $231.96, for a total value of $347,940.00. Following the completion of the sale, the vice president now directly owns 8,150 shares in the company, valued at $1,890,474. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, SVP Jody L. Bilney sold 4,600 shares of Humana stock in a transaction dated Friday, May 5th. The stock was sold at an average price of $230.16, for a total value of $1,058,736.00. Following the completion of the sale, the senior vice president now owns 8,978 shares of the company’s stock, valued at $2,066,376.48. The disclosure for this sale can be found here. Over the last quarter, insiders sold 138,270 shares of company stock valued at $31,253,863. Corporate insiders own 0.80% of the company’s stock.

About Humana

Humana Inc is a health and well-being company. The Company’s segments include Retail, Group, Healthcare Services and Other Businesses. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.

Receive News & Ratings for Humana Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply